Slowing pleural mesothelioma with gene targeting
For years in the UK, asbestos was used in the construction industry thanks to its versatility and fire-proofing properties. Although the dangers to health started to become known as early as the 1920’s, the use of asbestos continued and peaked in the 1960’s and 1970’s. It was not until 1985 when blue and brown asbestos […]
Mesothelioma T-cell immunotherapy trial
A US trial of T-cell immunotherapy for mesothelioma patients is showing promising results with minimal side effects. Mesothelioma is a cancer caused by asbestos. Currently, there is no cure, and treatment aims to reduce symptoms and improve quality of life for as long as possible. The standard treatment for mesothelioma in the UK has always […]
Nivolumab – New immunotherapy drug could treat mesothelioma, the cancer caused by asbestos
A new immunotherapy drug is currently being tested on 300 British patients. The new treatment has already been used for several other types of malignant tumour, but it is hoped that it will be an effective treatment for the asbestos cancer, mesothelioma, by harnessing the body’s own immune system in order to combat it. The […]
Hope for mesothelioma patients
A new drug has been developed in a laboratory in Melbourne, Australia, which has seen cancer tumours being shrunk. The next phase of the research is to undertake human trials to assess the drug’s benefits in treating mesothelioma, the asbestos related cancer. The aim is to begin the trials later this year. To date no […]
Can the thickness of a mesothelioma tumour highlight a patient’s treatment options?
A recent study conducted in the European Respiratory Journal, titled ‘Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma’, has pointed the way to help consultants determine the most appropriate course of action for mesothelioma sufferers. Mesothelioma is a malignant cancerous tumour that mainly develops as a result of […]